Skip to Content

Betaxolol Pregnancy and Breastfeeding Warnings

Betaxolol is also known as: Kerlone

Betaxolol Pregnancy Warnings

Animal studies at dose levels associated with maternal toxicity (600 times the maximum recommended human dose) have revealed postimplantation loss, skeletal and visceral abnormalities, and reductions in litter size and weight. Beta-adrenergic blocking agents decrease placental perfusion which may result in premature and immature deliveries and fetal death. There are no controlled data in human pregnancy.

Benefit should outweigh risk to the infant US FDA pregnancy category: C Comment: Monitor for the signs and symptoms of beta blockade (e.g., bradycardia, respiratory distress, and hypoglycemia) for 3 to 5 days after birth.

See references

Betaxolol Breastfeeding Warnings

Use caution; other beta-blocking agents may be preferred Excreted into human milk: Yes Comment: Breastfed infants should be monitored for the signs and symptoms of beta blockade, for example, bradycardia, respiratory distress, and hypoglycemia.

Beta-adrenergic blocking agents with similar lactation characteristics to this drug have caused adverse events in breastfed newborns. This drug is extensively excreted into breastmilk and is expected to have accumulation in the infant due to its low protein binding, low renal excretion, and long half-life.

See references

References for pregnancy information

  1. "Product Information. Kerlone (betaxolol)." Searle, Skokie, IL.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Kerlone (betaxolol)." Searle, Skokie, IL.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.